CurveBeam and Carestream Health signaled their commitment to weight-bearing computed tomography (CT) by announcing a collaborative effort to support education and research of the burgeoning modality.

Intelerad Medical Systems launched its latest comprehensive enterprise imaging system—called CosmosOne—in a bid to centralize patient information and provide an VNA companion to its workflow and enterprise viewing software.

ROCHESTER, N.Y., May 23 – Carestream Health has received an Innovative Technology contract from Vizient, Inc., for its CARESTREAM OnSight 3D Extremity System. Vizient is the largest member-driven health care performance improvement company in the country. The contract was based on a recommendation of Carestream’s OnSight 3D Extremity System by hospital experts with expertise in this category who serve on one of Vizient’s member-led councils. Innovative Technology contracts are reserved for technologies that demonstrate an ability to enhance clinical care or patient safety, and those that improve an organization’s care delivery and business model.

The Neiman Health Policy Institute is at it again, adding yet another online tool to help imaging practices make the right clinical and economic decisions. The institute released the Breast Screening Bundle Tool after a presentation at the American College of Radiology Annual Meeting.

Imaging practices are running out of time to integrate appropriate use criteria (AUC) into clinical workflows before the Protecting Access to Medicare Act (PAMA) requires it in 2018. However, the American College of Radiology (ACR)’s R-SCAN network both can prepare providers for the coming federal mandate while improving AUC for the specialty as a whole.

Google researchers, who have put their machine-learning expertise to work with consumer products like Translate and Images, are now stepping into the realm of healthcare.

Researchers from Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center revealed in a new study that diagnostic MRI followed by one of three MRI-guided biopsy strategies could be a cost-effective detection method for prostate cancer.

According to Forbes, lung cancer is the leading cause of death in China. With thousands of people being affected, it is increasingly difficult for radiologists to examine hundreds of images each day with complete accuracy.